Home
Deutsch
Advanced Search
Browse by ...
Publication overview
Contact persons
Help
Publ. Version/Full Text
Postprint
DOI
PMC
 |
Open Access Green |
as soon as is submitted to ZB.
Immune mechanisms in pulmonary fibrosis.
Am. J. Respir. Cell Mol. Biol. 55, 309-322 (2016)
Pulmonary fibrosis, particularly idiopathic pulmonary fibrosis, represents a chronic and progressive disease with high mortality and limited therapeutic options. Excessive deposition of extracellular matrix proteins results in fibrotic remodeling, alveolar destruction and irreversible loss of lung function. Both innate and adaptive immune mechanisms contribute to fibrogenesis at several cellular and non-cellular levels. Here, we summarize and discuss the role of immune cells (T cells, neutrophils, macrophages and fibrocytes) and soluble mediators (cytokines and chemokines) involved in pulmonary fibrosis, pointing towards novel immune-based therapeutic strategies in the field.
Altmetric
Additional Metrics?
Edit extra informations
Login
Publication type
Article: Journal article
Document type
Review
Keywords
T Cells ; Fibrosis ; Immunity ; Lung ; Neutrophils; Epithelial-mesenchymal Transition; Growth-factor-beta; Muc5b Promoter Polymorphism; Human Lung Fibroblasts; Regulatory T-cells; Gamma-delta T; Bronchoalveolar Lavage Fluid; Tyrosine Kinase Inhibitor; Versus-host-disease; Tgf-beta
ISSN (print) / ISBN
1044-1549
e-ISSN
1535-4989
Quellenangaben
Volume: 55,
Issue: 3,
Pages: 309-322
Publisher
American Thoracic Society
Publishing Place
New York
Non-patent literature
Publications
Reviewing status
Peer reviewed